2. Academic Validation
  3. XIAP-ULK1-Mediated mitophagy modulates carnitine metabolism to mitigate diabetic kidney disease

XIAP-ULK1-Mediated mitophagy modulates carnitine metabolism to mitigate diabetic kidney disease

  • Autophagy. 2025 Oct 25. doi: 10.1080/15548627.2025.2581214.
Hongtu Hu 1 2 3,  Rui Ji 3 4,  Yiqun Hao 5,  Zikang Liu 6,  Jian Yang 7,  Yun Cao 8,  Qian Yang 1 3
Affiliations

Affiliations

  • 1 Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
  • 2 Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
  • 3 Department of Nephrology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P. R. China.
  • 4 Reproductive Medical Center, Renmin Hospital of Wuhan University and Hubei Clinic Research, Wuhan, P. R. China.
  • 5 Department of Nephrology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, P. R. China.
  • 6 Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, P. R. China.
  • 7 Department of Nephrology, Hainan General Hospital (hainan Affiliated Hospital of Hainan Medical University), Haikou, P. R. China.
  • 8 Key Clinical Research Center of Kidney Disease in Hxubei, Wuhan, P. R. China.
PMID: 41139215 DOI: 10.1080/15548627.2025.2581214
Abstract

Diabetic kidney disease (DKD) is a major complication of diabetes, characterized by progressive renal dysfunction and mitochondrial impairment. Mitophagy, a selective form of macroautophagy/Autophagy that maintains mitochondrial quality, is essential for kidney homeostasis. However, the molecular mechanisms by which Mitophagy links these pathways to DKD remain poorly understood. This study investigated the role of XIAP-ULK1-mediated Mitophagy in regulating carnitine metabolism and its therapeutic potential in alleviating DKD. Through a combination of renal biopsy analysis from DKD patients, diabetic mouse models, high-glucose-treated tubular epithelial cells, and molecular docking, we determined that XIAP upregulation led to ULK1 degradation via K48-linked polyubiquitination, impairing Mitophagy and disrupting carnitine metabolism. Restoring ULK1 expression through the ULK1 agonist echinacoside and L-carnitine supplementation improved Mitophagy and carnitine homeostasis, reducing kidney injury and enhancing mitochondrial function in diabetic mouse models. These findings suggested that targeting the XIAP-ULK1 axis to restore Mitophagy and stabilize carnitine metabolism hold significant promise as a therapeutic strategy for DKD, highlighting the importance of metabolic regulation in kidney disease management.

Keywords

XIAP-ULK1 signaling; carnitine metabolism; diabetic kidney disease; mitochondrial dysfunction; mitophagy; therapeutic strategies.

Figures
Products